United States · Series B startup

Who invested in Orthocon

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Medical Devices

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2009, from 1 source

Latest round
Series B, $25MApr 2009
Investors
3
See who backed them

The rounds

  1. Apr 2009
    Series B$25M

    Reported by pehub.comSEC filing: $10M sold, first sale Mar 2009

Founders and team

From Orthocon's own website and the SEC filings it signed: 7 on the team.

  • John J. PacificoPresident and Chief Executive Officer
  • Brent AhrensBoard Member
  • Gary D. CohnBoard Member
  • John SfondriniBoard Member
  • David KnaackExecutive Officeri
  • Paul SohmerExecutive Officer, Directori
  • Richard KronenthalExecutive Officeri

On the board, as filediAlan LevyJoyce TsangKlaus BreinerSeth Rudnick

AdvisersDennis Podlesak

Everyone who backed them

CanaanVC firm1round
BB Biotech VenturesGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Orthocon

Who invested in Orthocon?

Orthocon's investors include Canaan, ProQuest Investments and BB Biotech Ventures.

How much has Orthocon raised?

Orthocon has raised $25M across 1 round since 2009.

When did Orthocon last raise?

Orthocon's most recent round was a Series B of $25M in Apr 2009.

What was Orthocon's biggest round?

Its most recent round, $25M in Apr 2009, is also its largest on record.

Who backed Orthocon first?

Orthocon's first round on record, in Apr 2009, was backed by Canaan, ProQuest Investments and BB Biotech Ventures.

What stage is Orthocon at?

Orthocon's latest named round is a Series B, in Apr 2009.

Where is Orthocon based?

Orthocon is based in the United States.

Companies like Orthocon

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.